# LUXFER HOLDINGS PLC (LXFR) FY 2024 MD&A

Verbatim Item 7 Management's Discussion and Analysis from LUXFER HOLDINGS PLC's 10-K for fiscal year 2024.

SEC filing source: https://www.sec.gov/Archives/edgar/data/1096056/000109605625000015/lxfr-20241231.htm
Accession: 0001096056-25-000015
Filing date: 2025-02-25
Report date: 2024-12-31
Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary.
Confidence: high

Company profile: /company/LXFR/
All MD&A years: /company/LXFR/mda/
Previous year: /company/LXFR/mda/fy2023/ (FY 2023)
Next year: /company/LXFR/mda/fy2025/ (FY 2025)

Item 7.        Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Annual Report on Form 10-K contains certain statements, statistics and projections that are, or may be, forward-looking. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Annual Report, as well as:

•general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;

•worldwide economic and business conditions and conditions in the industries in which we operate;

•potential or actual tariffs, and other political risks worldwide;

•our ability to execute our strategic review, including our Graphic Arts business, to safeguard margins and reduce costs;

•future pandemics;

•fluctuations in the cost and / or availability of raw materials, labor and energy, as well as our ability to pass on cost increases to customers;

•currency fluctuations and other financial risks;

•our ability to protect our intellectual property;

•the amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;

•relationships with our customers and suppliers;

•increased competition from other companies in the industries in which we operate;

•changing technology;

•our ability to execute and integrate new acquisitions;

•claims for personal injury, death or property damage arising from the use of products produced by us;

•the occurrence of accidents or other interruptions to our production processes;

•changes in our business strategy or development plans, and our expected level of capital expenditure;

•our ability to attract and retain qualified personnel;

•restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;

•climate change regulations and the potential impact on energy costs;

•regulatory, environmental, legislative and judicial developments; and

•our intention to pay dividends.

Please read the sections "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," of this Annual Report on Form 10-K for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

28

About Luxfer

Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Luxfer is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Key trends and uncertainties regarding our existing business

Uncertainty of demand in certain end-markets

Macro-economic conditions have continued to impact our general industrial end-market with demand remaining soft for products across all segments. We have also experienced variability of demand for certain products in our defense, first response & healthcare end-market, particularly defense applications, including countermeasure flares and flameless ration heaters, although we have seen this improve in the second half of the year. We have been able to navigate these challenges through productivity and cost management initiatives resulting in improved margins. Legal recoveries and effective working capital management contributed to excellent cash conversion and significantly reduced net debt levels.

While the outlook remains uncertain there are some signs of recovery within the industrial and defense end markets within our Elektron segment, which we are well-placed to capitalize on.

Operating objectives and trends

In 2025, we expect the following operating objectives and trends to impact our business:

•Addressing continuing general macro uncertainty and building resilience into the outlook;

•Ongoing focus on cost control and productivity improvements across the business to drive margin improvement, as well as new product launches to stimulate top line growth;

•Execution of actions identified upon completion of the previously announced expanded and accelerated strategic review, including the divestiture of Graphic Arts and Superform U.S.;

•Execution of selected capital investment projects to support our strategy of profitable growth while maintaining our infrastructure;

•Continued emphasis on operating cash generation and maintaining strong working capital performance;

•Further improvements in ESG standing through focus on sustainability and on our values of teamworking and accountability; and

•Focus on recruiting, developing and maintaining talent, while driving a high-performance culture.

29

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations from continuing operations of Luxfer were as follows:

[[GREPCENT_TABLE]]
[["","","","Years ended December 31,","","% / point change"],["","In millions","","2024","","2023","","2022","","2024 v 2023","","2023 v 2022"],["","Net sales","","$","391.9","","","$","405.0","","","$","423.4","","","(3.2)","%","","(4.3)","%"],["","Cost of sales","","(306.2)","","","(328.4)","","","(328.4)","","","(6.8)","%","","\u2014","%"],["","Gross profit","","85.7","","","76.6","","","95.0","","","11.9","%","","(19.4)","%"],["","% of net sales","","21.9","%","","18.9","%","","22.4","%","","3.0","","","(3.5)"],["","Selling, general and administrative expenses","","(48.1)","","","(48.7)","","","(43.1)","","","(1.2)","%","","13.0","%"],["","% of net sales","","12.3","%","","12.0","%","","10.2","%","","0.3","","","1.8"],["","Research and development","","(4.4)","","","(4.6)","","","(4.9)","","","(4.3)","%","","(6.1)","%"],["","% of net sales","","1.1","%","","1.1","%","","1.2","%","","\u2014","","","(0.1)"],["","Restructuring charges","","(4.7)","","","(6.4)","","","(1.9)","","","(26.6)","%","","236.8","%"],["","% of net sales","","1.2","%","","1.6","%","","0.4","%","","(0.4)","","","1.2"],["","Impairment charges","","\u2014","","","(12.7)","","","\u2014","","","(100.0)","%","","n/a"],["","% of net sales","","\u2014","%","","3.1","%","","\u2014","%","","(3.1)","","","3.1"],["","Acquisition and disposals costs","","(12.2)","","","\u2014","","","(0.3)","","","n/a","","(100.0)","%"],["","% of net sales","","3.1","%","","\u2014","%","","0.1","%","","3.1","","","(0.1)"],["","Other income","","7.7","","","\u2014","","","\u2014","","","n/a","","n/a"],["","% of net sales","","2.0","%","","\u2014","%","","\u2014","%","","2.0","","","\u2014"],["","Gain on disposal of assets held-for-sale","","6.1","","","\u2014","","","\u2014","","","n/a","","n/a"],["","% of net sales","","(1.6)","%","","\u2014","%","","\u2014","%","","(1.6)","","","\u2014"],["","Operating income","","30.1","","","4.2","","","44.8","","","616.7","%","","(90.6)","%"],["","% of net sales","","7.7","%","","1.0","%","","10.6","%","","6.7","","","(9.6)"],["","Net interest expense","","(5.2)","","","(6.3)","","","(3.9)","","","(17.5)","%","","61.5","%"],["","% of net sales","","1.3","%","","1.6","%","","0.9","%","","(0.3)","","","0.7"],["","Defined benefit pension credit / (charge)","","1.6","","","(7.6)","","","0.1","","","(121.1)","%","","(7,700.0)","%"],["","% of net sales","","0.4","%","","(1.9)","%","","\u2014","%","","2.3","","","(1.9)"],["","Income / (loss) before income taxes","","26.5","","","(9.7)","","","41.0","","","(373.2)","%","","(123.7)","%"],["","% of net sales","","6.8","%","","(2.4)","%","","9.7","%","","9.2","","","(12.1)"],["","(Provision) / credit for income taxes","","(8.2)","","","7.1","","","(9.0)","","","(215.5)","%","","(178.9)","%"],["","Effective tax rate","","30.9","%","","73.2","%","","22.0","%","","(42.3)","","","51.2"],["","Net income / (loss) from continuing operations","","$","18.3","","","$","(2.6)","","","$","32.0","","","(803.8)","%","","(108.1)","%"],["","% of net sales","","4.7","%","","(0.6)","%","","7.6","%","","5.3","","","(8.2)"]]
[[/GREPCENT_TABLE]]

30

Net sales

Adjusting for foreign exchange tailwinds of $1.7 million (2023: $0.3 million), consolidated net sales have decreased by 3.6% in 2024 from 2023. The adverse impact of volume and mix has accounted for a $16.0 million reduction in sales, while the passing through of price increases has slightly offset this decrease by $1.2 million.

While sales in our General Industrial and Transportation end markets have decreased by 9.2% and 5.7% respectively, our sales in our Defense, First Response and Healthcare end market have increased by 2.7%.

Overall sales have been negatively impacted by:

•Significant decrease in demand for zirconium products, particularly those used in automotive catalysis products;

•Lower sales of both commercial and defense aerospace alloys;

•Reductions in sales of chemical response kits following increased activity in the prior year clearing order backlogs;

•Lower sales for Alternative Fuel cylinders following lower demand in North America; and

•Decreased demand for photo-engraving plates.

These decreases were partially offset by:

•Increased sales of flameless ration heaters for meals ready to eat (MRE) and of our new unitized ration product ("UGR-E") ;

•Strong sales of magnesium alloys, particularly those used in automotive applications; and

•Stronger demand for SCBA cylinders as well as cylinders used in aerospace applications.

Gross profit

The 3.0 percentage point increase in gross profit as a percentage of sales in 2024 from 2023 was primarily the result of contract renegotiation and manufacturing efficiencies having a positive impact on margins within the Gas Cylinders and Elektron Divisions respectively. This has been partially offset by adverse volume and mix.

Selling, general and administrative expenses ("SG&A")

SG&A costs as a percentage of sales are relatively flat, having increased by 0.3 percentage points in 2024 from 2023. SG&A costs in 2023 included $5.9 million of legal costs in the Elektron Division. This activity relates to the legal case described in Note 22.

Research and development costs

Research and development costs as a percentage of sales remained flat in 2024 when compared to 2023 the overall spend of $4.4 million continues to show our commitment to new product development.

Restructuring charges

The $4.7 million restructuring charges in 2024 includes:

•$1.9 million of asset impairments and $1.8 million asset relocation, restructuring and other costs in relation to the rationalization of our North American Gas Cylinders businesses to reduce our fixed cost base;

•$0.1 million gain on disposal of Luxfer Gas Cylinders France site, offset by $0.9 million of costs incurred in relation to its closure; and

•$0.2 million of waste clean up costs in the Elektron division in relation to the consolidation of production facilities in the Magnesium Powders operations.

31

Impairment charges

The $12.7 million impairment charges incurred in 2023 arose from fully writing down property, plant and equipment and right of use assets from operating leases within our Graphic Arts division as a result of our annual impairment and strategic review.

Acquisition and disposals costs

In 2024 acquisition and disposal related costs of $12.2 million were incurred in relation to the divestiture of our Graphic Arts segment. $9.8 million represents a loss on held-for-sale asset group to reflect its fair value and $2.4 million represents professional fees. No acquisition and disposal related costs were incurred during 2023.

Other Income

Other Income of $7.7 million in 2024 relates to the recovery of legal costs from our insurer related to the previously disclosed US Ecology case, (see Note 22). Historically the legal costs relating to this case were in selling, general and administrative expenses. There was no other income in 2023.

Gain on Disposal of assets held for sale

The $6.1 million gain on disposal recognized in 2024 was in relation to the sale of previously disclosed held-for-sale land and buildings in our Elektron division. Net consideration of $7.3 million was received in the fourth quarter of 2024. There was no gain on disposal of assets held for sale in 2023.

Net interest expense

Net interest expense of $5.2 million in 2024 decreasing from $6.3 million in 2023 primarily due to the lower average drawings on the revolving credit facility.

Defined benefit pension credit

The defined benefit pension credit of $1.6 million in 2024, is in relation to the U.K. plan.

The defined benefit pension charge of $7.6 million in 2023, was predominantly the result of the sale of the U.S. pension plan liability to an insurer. There was a $9.0 million charge in relation to the sale, which included $2.1 million cash and $6.9 million in relation to the derecognition of the U.S. pension liability and reallocation of accumulated actuarial losses from other comprehensive income. An additional $0.3 million of interest cost was recognized in relation to the U.S. plan in the year. The 2023 charge was partially offset by a $1.7 million credit on the U.K. plan as expected return on assets outweighed the interest cost and net actuarial loss. This is consistent with the current year.

Provision for income taxes

The 42.3 percentage point decrease in the effective tax rate in 2024 from 2023 was primarily due to non-deductible expenses and deferred tax credit, predominantly in relation to the previously mentioned pension buy-out and impairment charges.

2023 compared with 2022

For a discussion comparing our consolidated operating results for the year ended December 31, 2023, with the year ended December 31, 2022, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the U.S. Securities and Exchange Commission on February 27, 2024. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2024.

32

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GAAP MEASURES

The following tables of non-GAAP summary financial data presents a reconciliation of net income from continuing operations and diluted earnings per ordinary share from continuing operations to adjusted net income from continuing operations, adjusted EBITA from continuing operations, adjusted income from continuing operations before income taxes, adjusted EBITDA from continuing operations, adjusted EBITDA excluding legal cost (recovery) / expense, adjusted earnings per ordinary share from continuing operations, adjusted provision for income taxes and adjusted effective tax rate from continuing operations, for the periods presented, being the most comparable GAAP measures. Management believes that adjusted net income excluding legal cost (recovery) / expense, adjusted earnings per share, adjusted EBITA and adjusted EBITDA excluding legal cost (recovery) / expense are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. In addition, Luxfer's CEO and other senior management use these KPIs, among others, to evaluate business performance. However, investors should not consider adjusted net income from continuing operations, adjusted earnings per share from continuing operations, adjusted EBITA from continuing operations and adjusted EBITDA excluding legal cost (recovery) / expense from continuing operations in isolation as an alternative to net income and earnings per share when evaluating Luxfer's operating performance or measuring Luxfer's profitability. In 2024, the Company initiated a process to divest the Graphic Arts business. While Graphic Arts does not meet the 'strategic shift' criteria outlined in ASC 205-20 for it to be classified as a discontinued operation, we believe that given the expectation that divestiture will be completed in the current year, it is appropriate in the tables below to separate out the results of Graphic Arts in order to provide a more complete financial summary for the period. Similarly for other Income of $7.7 million in 2024 relates to the recovery of legal costs from our insurer related to the previously disclosed US Ecology case, historically the legal costs relating to this case were in selling, general and administrative expenses, however the other income in 2024 is separated due to its one-off nature and the recovery relating to several years. We believe separating the income and costs relating to this is also appropriate to provide a more complete financial summary for the period.

[[GREPCENT_TABLE]]
[["","","Year-to-date"],["","In millions except per share data","2024","","2023"],["","","Continuing operations","Graphic Arts","Adjusted Total","","Continuing operations","Graphic Arts","Adjusted Total"],["","Net income / (loss)","$","18.3","","$","(13.9)","","$","32.2","","","$","(2.6)","","(14.9)","","$","12.3"],["","Accounting charges relating to acquisitions and disposals of businesses:"],["","Amortization on acquired intangibles","0.8","","\u2014","","0.8","","","0.8","","\u2014","","0.8"],["","Acquisition and disposal related charge","12.2","","12.2","","\u2014","","","\u2014","","\u2014","","\u2014"],["","Defined benefit pension (credit) / charge","(1.6)","","\u2014","","(1.6)","","","7.6","","\u2014","","7.6"],["","Restructuring charge","4.7","","\u2014","","4.7","","","6.4","","\u2014","","6.4"],["","Gain on disposal of assets held-for-sale","(6.1)","","\u2014","","(6.1)","","","\u2014","","\u2014","","\u2014"],["","Impairment charge","\u2014","","\u2014","","\u2014","","","12.7","","12.7","","\u2014"],["","Share-based compensation charge","3.5","","0.5","","3.0","","","2.8","","\u2014","","2.8"],["","Tax impact of defined benefit settlement","\u2014","","\u2014","","\u2014","","","(4.9)","","\u2014","","(4.9)"],["","Income tax on adjusted items","(0.9)","","(0.6)","","(0.3)","","","(6.4)","","(3.0)","","(3.4)"],["","Adjusted net income / (loss)","30.9","","(1.8)","","32.7","","","16.4","","(5.2)","","21.6"],["","Less:"],["","Legal cost (recovery) / expense","(7.7)","","\u2014","","(7.7)","","","5.9","","\u2014","","5.9"],["","Tax on legal cost recovery / (expense)","1.8","","\u2014","","1.8","","","(1.2)","","\u2014","","(1.2)"],["","Adjusted net income / (loss) excluding legal cost (recovery) / expense","$","25.0","","$","(1.8)","","$","26.8","","","$","21.1","","$","(5.2)","","$","26.3"],["","Adjusted earnings / (loss) per ordinary share (1)"],["","Diluted earnings / (loss) per ordinary share","$","0.68","","$","(0.51)","","$","1.19","","","$","(0.10)","","$","(0.55)","","$","0.45"],["","Impact of adjusted items","0.46","","0.44","","0.02","","","0.71","","0.36","","0.35"],["","Adjusted diluted earnings / (loss) per ordinary share","$","1.14","","$","(0.07)","","$","1.21","","","$","0.61","","$","(0.19)","","$","0.80"],["","Impact of legal cost (recovery) / expense","(0.22)","","\u2014","","(0.22)","","","0.17","","\u2014","","0.17"],["","Adjusted diluted earnings / (loss) per ordinary share excluding legal cost recovery / expense","$","0.92","","$","(0.07)","","$","0.99","","","$","0.78","","$","(0.19)","","$","0.97"]]
[[/GREPCENT_TABLE]]

(1) For the purpose of calculating diluted earnings per share, the weighted average number of ordinary shares outstanding during the financial year has been adjusted for the dilutive effects of all potential ordinary shares and share options granted to employees.

33

[[GREPCENT_TABLE]]
[["","","Year-to-date"],["","In millions except per share data","2024","","2023"],["","","Continuing operations","Graphic Arts","Adjusted Total","","Continuing operations","Graphic Arts","Adjusted Total"],["","Adjusted net income from continuing operations","$","30.9","","$","(1.8)","","$","32.7","","","$","16.4","","$","(5.2)","","$","21.6"],["","Add back:"],["","Income tax on adjusted items","0.9","","0.6","","0.3","","","6.4","3.0","","3.4"],["","Income tax expense","8.2","","(1.3)","","9.5","","","(7.1)","","(4.1)","","(3.0)"],["","Tax impact of defined benefit pension settlement","\u2014","","\u2014","","\u2014","","","4.9","","\u2014","","4.9"],["","Net finance costs","5.2","","(0.4)","","5.6","","","6.3","","(0.2)","","6.5"],["","Adjusted EBITA","45.2","","(2.9)","","48.1","","","26.9","","(6.5)","","33.4"],["","Loss on disposal of property, plant and equipment","0.1","","\u2014","","0.1","","","\u2014","","\u2014","","\u2014"],["","Depreciation","9.3","","\u2014","","9.3","","","11.9","","2.0","","9.9"],["","Adjusted EBITDA","54.6","","(2.9)","","57.5","","","38.8","","(4.5)","","43.3"],["","Less:"],["","Legal cost (recovery) / expense","(7.7)","","\u2014","","(7.7)","","","5.9","","\u2014","","5.9"],["","Adjusted EBITDA excluding legal cost (recovery) / expense","$","46.9","","$","(2.9)","","$","49.8","","","$","44.7","","$","(4.5)","","$","49.2"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","","Year-to-date"],["","In millions except per share data","2024","","2023"],["","","Continuing operations","Graphic Arts","Adjusted Total","","Continuing operations","Graphic Arts","Adjusted Total"],["","Adjusted net income / (loss) from continuing operations","$","30.9","","$","(1.8)","","$","32.7","","","$","16.4","","$","(5.2)","","$","21.6"],["","Add back:"],["","Income tax on adjusted items","0.9","","0.6","","0.3","","","6.4","","3.0","","3.4"],["","Tax impact of defined benefit pension settlement","\u2014","","\u2014","","\u2014","","","4.9","","\u2014","","4.9"],["","Provision / (credit) for income taxes","8.2","","(1.3)","","9.5","","","(7.1)","","(4.1)","","(3.0)"],["","Adjusted income / (loss) from continuing operations before income taxes","40.0","","(2.5)","","42.5","","","20.6","","(6.3)","","26.9"],["","Adjusted provision (credit) for income taxes","9.1","","(0.7)","","9.8","","","4.2","","(1.1)","","5.3"],["","Adjusted effective tax rate from continuing operations","22.8","%","28.0","%","23.1","%","","20.4","%","17.5","%","19.7","%"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","","2024"],["","In millions","Gas Cylinders","","Elektron","","Graphic Arts","","Total"],["","Segment adjusted EBITA","$","14.6","","","$","33.5","","","$","(2.9)","","","$","45.2"],["","Depreciation","3.4","","","5.9","","","\u2014","","","9.3"],["","Loss on disposal of property, plant and equipment","\u2014","","","0.1","","","\u2014","","","0.1"],["","Segment adjusted EBITDA","$","18.0","","","$","39.5","","","$","(2.9)","","","$","54.6"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","","2023"],["","In millions","Gas Cylinders","","Elektron","","Graphic Arts","","Total"],["","Segment adjusted EBITA","$","12.6","","","$","20.8","","","$","(6.5)","","","$","26.9"],["","Depreciation","4.1","","","5.8","","","2.0","","","$","11.9"],["","Segment adjusted EBITDA","$","16.7","","","$","26.6","","","$","(4.5)","","","$","38.8"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["","","2022"],["","In millions","Gas Cylinders","","Elektron","","Graphic Arts","","Total"],["","Segment adjusted EBITA","$","8.0","","","$","36.6","","","$","5.6","","","$","50.2"],["","Depreciation","4.8","","","5.9","","","2.2","","","12.9"],["","Segment adjusted EBITDA","$","12.8","","","$","42.5","","","$","7.8","","","$","63.1"]]
[[/GREPCENT_TABLE]]

34

SEGMENT RESULTS OF OPERATIONS

The summary that follows provides a discussion of the results of operations of each of our three reportable segments (Gas Cylinders, Elektron and Graphic Arts). The three segments comprise various product offerings that serve multiple end-markets.

In 2023, the Graphic Arts reporting segment was disaggregated from the Elektron segment and in 2024 and 2023 is being reported separately as the Graphic Arts segment. The Elektron segment's results for 2022 have been adjusted to strip out Graphic Arts' results.

Adjusted EBITA, which is our segment income metric, represents net income from continuing operations adjusted for share-based compensation charges, restructuring charges, impairment charges, other charges, acquisitions and disposals costs, net interest expenses, defined benefits pension credit, provision for taxes and amortization. A reconciliation to pre-tax income can be found in ITEM 8, Note 18. Adjusted EBITDA, as shown below, represents adjusted EBITA less depreciation. Management believes that adjusted EBITA and adjusted EBITDA are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. Adjusted EBITDA is reconciled to adjusted EBITA above.

GAS CYLINDERS

The results of operations from the Gas Cylinders segment are for continuing operations only.

The net sales, adjusted EBITA and adjusted EBITDA for Gas Cylinders were as follows:

[[GREPCENT_TABLE]]
[["","","","Years ended December 31,","","% / point change"],["","In millions","","2024","","2023","","2022","","2024 v 2023","","2023 v 2022"],["","Net sales","","$","186.3","","","$","186.4","","","$","183.7","","","(0.1)","%","","1.5","%"],["","Adjusted EBITA","","14.6","","","12.6","","","8.0","","","15.9","%","","57.5","%"],["","Adjusted EBITDA","","18.0","","","16.7","","","12.8","","","7.8","%","","30.5","%"],["","Adjusted EBITA % of net sales","","7.8","%","","6.8","%","","4.4","%","","1.0","","","2.4"],["","Adjusted EBITDA % of net sales","","9.7","%","","9.0","%","","7.0","%","","0.7","","","2.0"]]
[[/GREPCENT_TABLE]]

Net sales

The 0.1% decrease in Gas Cylinders sales in 2024 from 2023 was primarily the result of:

•Lower sales of Alternative Fuels cylinders;

•Industrial cylinders' sales being weaker in the year.

These increases have been largely offset by:

•Price increases throughout the segment as contracts are renegotiated; and

•Increased volumes of our medical and aerospace cylinders.

Adjusted EBITA

The 1.0 percentage point increase in adjusted EBITA for Gas Cylinders as a percentage of net sales in 2024 from 2023 is predominantly the result of pricing improvements from new sales contracts partially offset by adverse sales mix and volume.

Adjusted EBITDA

The 0.7 percentage point increase in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2024 from 2023 is predominantly the result of the increase in adjusted EBITA as a percentage of net sales.

35

ELEKTRON

The net sales, adjusted EBITA and adjusted EBITDA for Elektron were as follows:

[[GREPCENT_TABLE]]
[["","","","Years ended December 31,","","% / point change"],["","In millions","","2024","","2023","","2022","","2024 v 2023","","2023 v 2022"],["","Net sales","","$","176.0","","","$","187.1","","","$","201.0","","","(5.9)","%","","(6.9)","%"],["","Adjusted EBITA","","33.5","","","20.8","","","36.6","","","61.1","%","","(43.2)","%"],["","Adjusted EBITDA","","39.5","","","26.6","","","42.5","","","48.5","%","","(37.4)","%"],["","Adjusted EBITA % of net sales","","19.0","%","","11.1","%","","18.2","%","","7.9","","","(7.1)"],["","Adjusted EBITDA % of net sales","","22.4","%","","14.2","%","","21.1","%","","8.2","","","(6.9)"]]
[[/GREPCENT_TABLE]]

Net sales

The 5.9% decrease in Elektron sales in 2024 from 2023 was primarily the result of:

•Significant decrease in demand for zirconium products, particularly those used in automotive catalysis products;

•Lower sales of both commercial and defense aerospace alloys; and

•Reductions in chemical response kit and commercial magnesium powder sales.

These decreases were partially offset by:

•Increased sales of flameless ration heaters for meals ready to eat (MRE) and of our new unitized ration product ("UGR-E") ;

•Strong sales of magnesium alloys, particularly those used in automotive applications;

•Increased magnesium alloy sales to the Oil and Gas industry.

Adjusted EBITA

The 7.9 percentage point increase in adjusted EBITA for Elektron as a percentage of net sales in 2024 from 2023 was a result of the net recovery from the previously disclosed US Ecology case in 2024 of $7.7 million, compared to the net cost of $5.9 million in 2023. This was partially offset by adverse price.

Adjusted EBITDA

The 8.2 percentage point increase in adjusted EBITDA for Elektron as a percentage of net sales in 2024 from 2023 was predominantly the result of the increase in adjusted EBITA as a percentage of net sales.

GRAPHIC ARTS

The net sales, adjusted EBITA and adjusted EBITDA for Graphic Arts were as follows:

[[GREPCENT_TABLE]]
[["","","","Years ended December 31,","","% / point change"],["","In millions","","2024","","2023","","2022","","2024 v 2023","","2023 v 2022"],["","Net sales","","$","29.6","","","$","31.5","","","$","38.7","","","(6.0)","%","","(18.6)","%"],["","Adjusted EBITA","","(2.9)","","","(6.5)","","","5.6","","","(55.4)","%","","(216.1)","%"],["","Adjusted EBITDA","","(2.9)","","","(4.5)","","","7.8","","","(35.6)","%","","(157.7)","%"],["","Adjusted EBITA % of net sales","","(9.8)","%","","(20.6)","%","","14.5","%","","10.8","","","(35.1)"],["","Adjusted EBITDA % of net sales","","(9.8)","%","","(14.3)","%","","20.2","%","","4.5","","","(34.5)"]]
[[/GREPCENT_TABLE]]

Net sales

The 6.0% decrease in Graphic Arts sales in 2024 from 2023 was primarily the result of fluctuating demand for photo-engraving plates, particularly outside the North American market.

Adjusted EBITA

The loss in 2024 for Graphic Arts was a result of relatively high magnesium raw material cost amid increased competition. 2023 was significantly impacted by significant material cost inflation resulting in competitive constraints. Magnesium purchase price has reduced throughout 2024, although there is typically a lag before this impact is recognized in the income statement through lower cost of sales.

Adjusted EBITDA

The loss in 2024 for Graphic Arts was a result of the factors above, in accordance with ASC 360, depreciation did not impact 2024 as no depreciation is charged on assets held for sale.

36

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity requirements arise primarily from obligations under our indebtedness, capital expenditures, acquisitions, the funding of working capital and the funding of hedging facilities to manage foreign exchange and commodity purchase price risks. We meet these requirements primarily through cash flows from operating activities, cash deposits and borrowings under the Revolving Credit Facility and accompanying ancillary hedging facilities and the Loan Note due in 2026. Our principal liquidity needs are:

•funding acquisitions, including deferred contingent consideration payments;

•capital expenditure requirements;

•payment of shareholder dividends;

•servicing interest on the Loan Notes, which is payable at each quarter end, in addition to interest and / or commitment fees on the Senior Facilities Agreement;

•working capital requirements, particularly in the short term as we aim to achieve organic sales growth; and

•hedging facilities used to manage our foreign exchange risks and aluminum purchase price risks.

We believe that, in the long term, cash generated from our operations will be adequate to meet our anticipated requirements for working capital, capital expenditures and interest payments on our indebtedness. In the short term, we believe we have sufficient credit facilities to cover any variation in our cash flow generation. However, any major repayments of indebtedness will be dependent on our ability to raise alternative financing or to realize substantial returns from operational sales. Also, our ability to expand operations through sales development and capital expenditures could be constrained by the availability of liquidity, which, in turn, could impact the profitability of our operations.

We have been in compliance with the covenants under the Loan Notes and the RCF throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2024.

Luxfer conducts all of its operations through its subsidiaries, joint ventures and affiliates. Accordingly, Luxfer's main cash source is dividends from its subsidiaries. The ability of each subsidiary to make distributions depends on the funds that a subsidiary receives from its operations in excess of the funds necessary for its operations, obligations or other business plans. We have not historically experienced any material impediment to these distributions, and we do not expect any local legal or regulatory regimes to have any impact on our ability to meet our liquidity requirements in the future. In addition, since our subsidiaries are wholly-owned, our claims will generally rank junior to all other obligations of the subsidiaries. If our operating subsidiaries are unable to make distributions, our growth may slow, unless we are able to obtain additional debt or equity financing. In the event of a subsidiary's liquidation, there may not be assets sufficient for us to recoup our investment in the subsidiary.

Our ability to maintain or increase the generation of cash from our operations in the future will depend significantly on the competitiveness of and demand for our products, including our success in launching new products. Achieving such success is a key objective of our business strategy. Due to commercial, competitive and external economic factors, however, we cannot guarantee that we will generate sufficient cash flows from operations or that future working capital will be available in an amount sufficient to enable us to service our indebtedness or make necessary capital expenditures.

Cash Flows from Continuing Operations

Operating activities

Cash provided by operating activities was $51.1 million and $26.2 million in 2024 and 2023 respectively, which includes approximately $5.0 million and $3.6 million of cash spent on restructuring activities in those years. Cash was primarily related to the net income / loss from operating activities, net of the following non-cash items: depreciation and amortization; share-based compensation charges; pension credit / (charge); gain on disposal of held for sale assets; loss on held-for-sale asset group and net changes to assets and liabilities. Cash flow was impacted by the $5.8 million receipt arising from the reimbursement of legal costs in relation to the previously disclosed US Ecology case, whereas 2023 had an outflow of $5.9 million. Also impacting the 2023 cash flow was the $2.1 million contribution the Company made in relation to the sale of the U.S. pension plan to an insurer.

Investing activities

Net cash used for investing activities was $3.4 million in 2024, compared to $9.4 million in 2023. The following investing activities impacted our cash flow:

Capital expenditures

37

Capital expenditures in 2024 was $10.3 million compared to $9.4 million in 2023. We anticipate capital expenditures for 2025 to be between $12 million and $15 million as we increase investment in order to grow the business.

Proceeds from assets held for sale

In September 2024, the Company sold a previously held-for-sale building in the Elektron segment for $7.3 million. Consideration was paid in full in October 2024.

Financing activities

In 2024, net cash used for financing activities was $44.0 million, (2023: $27.5 million). We repaid $1.5 million of bank overdraft, made net repayments on our borrowing facilities of $25.7 million (2023: net drawdowns of $10.2 million) and dividend payments of $14.0 million (2023: $14.0 million), equating to $0.52 per ordinary share (2023: $0.52 per ordinary share). In 2024, the Company spent $2.3 million repurchasing approximately 200,000 shares, (2023: $2.7 million repurchasing approximately 200,000 shares).

Loan Note 2026

The Note Purchase Agreement contains customary covenants and events of default, in each case with customary and appropriate grace periods and thresholds. In addition, the Note Purchase Agreement requires us to maintain compliance with a minimum interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Note Purchase Agreement) to Net Finance Charges (as defined in the Note Purchase Agreement). We are required to maintain an interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Note Purchase Agreement) to Adjusted Acquisition EBITDA (as defined in the Note Purchase Agreement). We are required to maintain a leverage ratio of no more than 3.0:1. We have been in compliance with the covenants under the Note Purchase Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2024. The Loan Note due 2026 and the Note Purchase Agreement are governed by the law of the State of New York.

The Loan Note due 2026 is denominated in U.S. dollars, which creates a natural partial offset between the dollar-denominated net assets and earnings of our U.S. operations and the dollar-denominated debt and related interest expense of the notes. We have included the Note Purchase Agreement and a form of the Loan Note due 2026 as exhibits to this Annual Report and refer you to the exhibits for more information on the Note Purchase Agreement and the Loan Note due 2026.

Senior Facilities Agreement

A Senior Facilities Agreement was signed in October 2021, for more information see ITEM 8 Note 12.

Structure. At December 31, 2024 the Senior Facilities Agreement provided $125 million of committed debt facilities in the form of a multi-currency (GBP sterling, U.S. dollars or euros) RCF and an additional $25 million of uncommitted facilities through an accordion clause. The facilities mature in October 2026. As of December 31, 2024, we had drawn down $17.2 million under the Revolving Credit Facility (December 31, 2023: $43.1 million).

38

Availability.    The facility is used for loans and overdrafts. Amounts unutilized under the RCF (or, if the case, under the revolving portion of the accordion) are allocated to ancillary facilities available under the Senior Facilities Agreement in connection with overdraft facilities, bilateral loan facilities and letter of credit facilities. As of December 31, 2024, we had drawn down $2.8 million under the ancillary facilities (December 31, 2023: $2.2 million). We may use amounts drawn under the RCF for our general corporate purposes and certain capital expenditures, as well as for the financing of permitted acquisitions and reorganizations. As of December 31, 2024, $107.8 million (net of $17.2 million drawn down) was available under the RCF. The last month in which we may draw funds from the RCF is September 2026.

The Company also had a separate (uncommitted) bonding facility for bank guarantees; denominated in GBP sterling totaling £0.5 million ($0.6 million) and £0.1 million ($0.2 million) was utilized at December 31, 2024.

Interest rates and fees.    Borrowings under the facility bear an interest rate equal to an applicable margin plus either EURIBOR, in the case of amounts drawn in euros, or SONIA (Sterling Overnight Index Average), in the case of amounts drawn in GBP sterling or U.S. dollars.

The tables below sets out the range of ratios and the related margin percentage currently in effect.

[[GREPCENT_TABLE]]
[["Leverage","","Margin"],["","(% per annum)"],["Greater than 2.5:1","2.75"],["Less than or equal to 2.5:1, but greater than 2.0:1","2.50"],["Less than or equal to 2.0:1, but greater than 1.5:1","2.25"],["Less than or equal to 1.5:1, but greater than 1.0:1","2.00"],["Less than or equal to 1.0:1","1.75"]]
[[/GREPCENT_TABLE]]

As of December 31, 2024, we had drawn down $17.2 million under the RCF (December 31, 2023: $43.1 million). A commitment fee is levied each quarter against any unutilized element of the RCF, excluding overdraft or ancillary facilities.

In the event of a sale of all or substantially all of our business and / or assets, or if any person or group of persons acting in concert gains direct or indirect control (as defined in the Senior Facilities Agreement) of Luxfer Holdings PLC, we will be required to immediately repay all outstanding amounts under the RCF (and, if the case, the accordion) and the ancillary facilities under the Senior Facilities Agreement.

In addition, the Senior Facilities Agreement requires us to maintain compliance with an interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Senior Facilities Agreement) to Net Finance Charges (as defined in the Senior Facilities Agreement). We are required to maintain a minimum interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Senior Facilities Agreement) to the Relevant Period Adjusted Acquisition EBITDA (as defined in the Senior Facilities Agreement). We are required to maintain a leverage ratio of no more than 3.0:1.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2024.

The Senior Facilities Agreement is governed by English law. For more information see ITEM 8, Note 12.

Dividends

We paid dividends in 2024 of $14.0 million (2023: $14.0 million), or $0.52 (2023: $0.52) per ordinary share.

Any payment of dividends is also subject to the provisions of the U.K. Companies Act, according to which dividends may only be paid out of profits available for distribution determined by reference to financial statements prepared in accordance with the Companies Act and the International Accounting Standards Board, which differ in some respects from U.S. GAAP. In the event that dividends are paid in the future, holders of the ordinary shares will be entitled to receive payments in U.S. dollars in respect of dividends on the underlying ordinary shares in accordance with the deposit agreement. Furthermore, because we are a holding company, any dividend payments would depend on cash flows from our subsidiaries.

Authorized shares

Our authorized share capital consists of 40.0 million ordinary shares with a par value of £0.50 per share.

39

Contractual obligations

The following summarizes our significant contractual obligations that impact our liquidity:

[[GREPCENT_TABLE]]
[["","Payments Due by Period"],["In millions","Total","","Less than 1 year","","1 \u2013 3 years","","3 \u2013 5 years","","After 5 years"],["Contractual cash obligations"],["Loan Notes due 2026","$","25.0","","","$","\u2014","","","$","25.0","","","$","\u2014","","","$","\u2014"],["Revolving Credit Facility due October 2026","17.2","","","\u2014","","","17.2","","","\u2014","","","\u2014"],["Bank overdraft","3.1","","","3.1","","","\u2014","","","\u2014","","","\u2014"],["Obligations under operating leases","20.2","","","4.6","","","5.7","","","2.2","","","7.7"],["Capital commitments","0.5","","","0.5","","","\u2014","","","\u2014","","","\u2014"],["Interest payments","3.7","","","2.3","","","1.4","","","\u2014","","","\u2014"],["Total contractual cash obligations","$","69.7","","","$","10.5","","","$","49.3","","","$","2.2","","","$","7.7"]]
[[/GREPCENT_TABLE]]

2023 compared with 2022

For a discussion comparing our net cash activities (operating, investing and financing) for the year ended December 31, 2023, with the year ended December 31, 2022, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the U.S. Securities and Exchange Commission on February 27, 2024. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2024.

Off-balance sheet measures

At December 31, 2024, we had no off-balance sheet arrangements other than the three bonding facilities as described above.

COMMITMENTS AND CONTINGENCIES

Capital commitments

At December 31, 2024, the Company had capital expenditure commitments of $0.5 million (2023: $2.3 million and 2022: $1.4 million) for the purchase of new plant and equipment.

Committed banking facilities

At December 31, 2024 and December 31, 2023 the Company had committed banking facilities of $125.0 million with an additional $25.0 million of uncommitted facilities through an accordion provision. Of these committed facilities, $17.2 million was drawn at December 31, 2024 ($43.1 million December 31, 2023). The banking facilities expire in October 2026.

Contingencies

In December 2023, it was established that any potential liability arising from the lawsuits and reasonable defense costs related to the US Ecology case (see Note 22) are covered by insurance. The Company recognized $7.7 million within other income in the twelve months of 2024, in relation to these costs previously incurred by the Company. $5.8 million cash has been received in 2024 and a final $1.9 million has been received post year end, included within accounts and other receivables.

NEW ACCOUNTING STANDARDS

See ITEM 8, Note 1 of the notes to the Consolidated Financial Statements, included in this Form 10-K, for information pertaining to recently adopted accounting standards or accounting standards to be adopted in the future.

40

CRITICAL ACCOUNTING ESTIMATES    

We have adopted various accounting policies to prepare the consolidated financial statements in accordance with GAAP. Our significant accounting policies are more fully described in ITEM 8, Note 1 of the Notes to Consolidated Financial Statements. Certain accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, terms of existing contracts, our observance of trends in the industry and information available from other outside sources, as appropriate. We consider an accounting estimate to be critical if:

•it requires us to make assumptions about matters that were uncertain at the time we were making the estimate; and

•changes in the estimate or different estimates that we could have selected would have had a material impact on our financial condition or results of operations.

Our critical accounting estimates include the following:

Impairment of goodwill

Goodwill

Goodwill represents the excess of the cost of acquired businesses over the net of the fair value of identifiable net assets purchased and liabilities assumed.

Goodwill is tested at least annually for impairment and is tested for impairment more frequently if events or changes in circumstances indicate that the asset might be impaired. Goodwill is tested for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all reporting units and perform a quantitative impairment test. Management carried out its qualitative review on the last day of the third quarter in 2024 and 2023. Our qualitative review showed no indicators of impairment in segments carrying goodwill. As a result, the Company concluded its review and was not required to perform a quantitative review.

U.K. Defined Benefit Pension Plan

The Company operates a funded defined benefit pension plan in the U.K., and immaterial plans in the U.S. and France. The amounts recognized in our consolidated financial statements related to our defined-benefit pension and other post-retirement plans are determined from actuarial valuations. Inherent in these valuations are assumptions, including: (i) discount rates; (ii) inflation rates; (iii) pension increases; and (iv) life expectancy. These assumptions are updated annually and are disclosed in ITEM 8, Note 15 to the Notes to Consolidated Financial Statements. Differences in actual experience or changes in assumptions can have a material impact on the pension and other post-retirement obligations and future expense.

We recognize changes in the fair value of plan assets and net actuarial gains or losses for pension and other post-retirement benefits annually in the fourth quarter each year ("mark-to-market adjustment") and, if applicable, in any quarter in which an interim remeasurement is triggered. Net actuarial gains and losses occur when the actual experience differs from any of the various assumptions used to value our pension and other post-retirement plans or when assumptions change as they may each year. The primary factors contributing to actuarial gains and losses each year are (i) changes in the discount rate used to value pension and other post-retirement benefit obligations as of the measurement date and (ii) differences between the expected and the actual return on plan assets. This accounting method also results in the potential for volatile and difficult to forecast mark-to-market adjustments. The remaining components of pension expense, including service and interest costs and the expected return on plan assets, are recorded on a quarterly basis as ongoing pension expense.

Discount rate

The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the Plan’s liabilities. This yield produced a weighted-average discount rate for our U.K. plans of 5.40% in 2024, 4.50% in 2023 and 4.80% in 2022. The discount rate on our U.S. plans was n/a in 2024 and 2023, and 5.10% in 2022. There are no known or anticipated changes in our discount rate assumption that will impact our pension expense in 2025.

To indicate the sensitivity of results to this assumption, a 0.1% per annum increase in the discount rate for our U.K. plans would reduce the value of the liabilities and therefore increase the pension surplus by approximately $2.5 million and increase the projected 2025 income statement credit by approximately $0.1 million.

41

Inflation rate

In September 2019, the UK Statistics Authority announced plans to reform the RPI inflation index. On November 25, 2020, the government and UK Statistics Authority confirmed these plans to reform the RPI index to bring it into line with the CPIH index from 2030, with no compensation for the holders of index-linked gilts. Inflation measured by the CPIH is consistently significantly lower than that measured by RPI, and therefore, these plans imply a significant expected reduction in RPI inflation from 2030 onwards. As a result we have taken a stepped approach and used different inflation rates pre and post 2030.

To indicate the sensitivity of results to the CPI assumption, a 0.1% per annum decrease in all CPI-linked assumptions, (including pension increases) for our U.K. plan, would reduce the value of the liabilities and therefore increase the pension surplus at December 31, 2024 by approximately $1.3 million and increase the projected 2024 income statement credit by approximately $0.1 million.

Pension increases

The pension increase assumptions have been set with reference to the corresponding CPI inflation assumption and take account of the caps and floors applicable to the various components of pension indexation.

Life expectancy

The life expectancies of male and female members aged 65 on 31 December 2024 are assumed to be 20.1 and 22.7 years, respectively, with the life expectancies of male and female members aged 65 on 31 December 2044 assumed to be 21.3 and 24.1 years, respectively.

To indicate the sensitivity of results to the life expectancy assumption, a one year increase in assumed life expectancy on the U.K. plan could increase the value of the liabilities and therefore decrease the pension surplus at December 31, 2024 by approximately $6.3 million.

Expected rate of return

Our expected rate of return on plan assets for our U.K. plans was 5.80% in 2024, 4.80% in 2023 and 5.60% in 2022. The expected rate of return on our U.S. plans was n/a in 2024 and 2023, and 4.70% in 2022. The expected rate of return is designed to be a long-term assumption that may be subject to considerable year-to-year variance from actual returns. In developing the expected long-term rate of return, we considered our historical returns, with consideration given to forecast economic conditions, our asset allocations, input from external consultants and broader longer-term market indices.

See ITEM 8, Note 15 of the Notes to Consolidated Financial Statements for further information regarding pension and other post-retirement plans.

42